Results 211 to 220 of about 81,525 (242)

Physician-Delegated Unobserved Induction with Buprenorphine in Pharmacies

New England Journal of Medicine, 2023
Traci C Green
exaly  

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2019
Mark K Greenwald, Vijay R Nadipelli, Christian Heidbreder   +2 more
exaly  

Perioperative Buprenorphine

Journal of PeriAnesthesia Nursing, 2019
openaire   +2 more sources

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial

Lancet, The, 2003
Johan Kakko, Mary Jeanne Kreek, Markus Heilig   +2 more
exaly  

Buprenorphine

Reactions Weekly, 2004
openaire   +2 more sources

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Lancet, The, 2018
Joshua D Lee, Edward V Nunes, Marc Fishman   +2 more
exaly  

Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder

American Journal of Psychiatry, 2020
Hillary Samples, Stephen Crystal, Mark Olfson   +2 more
exaly  

Buprenorphine

Reactions Weekly, 2015
openaire   +2 more sources

Buprenorphine

Journal of Exotic Pet Medicine, 2019
openaire   +2 more sources

Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone

New England Journal of Medicine, 2003
Susan M Stine
exaly